Glycerin + Hypromellose + Polyethylene glycol + Tetrahydrozoline + Zinc Sulfate interactions

Checked as Glycerin + Tetryzoline (ophthalmic) + Zinc sulfate in this data source.

Full monograph for Glycerin + Hypromellose + Polyethylene glycol + Tetrahydrozoline + Zinc Sulfate Check it against another medicine

Medicines

285 documented

Severity

Mechanism

Medicines documented to interact with Glycerin + Hypromellose + Polyethylene glycol + Tetrahydrozoline + Zinc Sulfate, worst severity first.
Medicine	Severity	Mechanism	Effect	Sources
Ergometrine Maleatevia Tetryzoline (ophthalmic)	Major	Synergy	Additive or synergistic increases in blood pressure and/or ischemic response may occur when ergot alkaloids are combined with peripheral or central…	38 sources — open the full entry
Methylergonovine Maleatevia Tetryzoline (ophthalmic)	Major	Synergy	Additive or synergistic increases in blood pressure and/or ischemic response may occur when ergot alkaloids are combined with peripheral or central…	38 sources — open the full entry
Abiraterone Acetatevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Acetazolamidevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Aclidinium Bromide + Formoterol Fumaratevia Tetryzoline (ophthalmic)	Moderate	Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…	11 sources — open the full entry
Acyclovir + Hydrocortisonevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Alendronic acidvia Zinc sulfate	Moderate	Absorption	INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to…	9 sources — open the full entry
Alendronic Acid + Vitamin D3via Zinc sulfate	Moderate	Absorption	INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to…	9 sources — open the full entry
Alfuzosin Hydrochloridevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Amiodarone Hydrochloridevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Amisulpridevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Amlodipine Besilate + Benazepril Hydrochloridevia Glycerin	Moderate	Synergy	Although they are frequently combined in clinical practice, diuretics and angiotensin converting enzyme (ACE) inhibitors may have additive effects…	26 sources — open the full entry
Apalutamidevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Arformoterol Tartratevia Tetryzoline (ophthalmic)	Moderate	Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…	11 sources — open the full entry
Arsenic Trioxidevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Artemether + Lumefantrinevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…2 documented mechanisms	12 sources — open the full entry
Asciminibvia Zinc sulfate, Glycerin	Moderate	Others · Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…2 documented mechanisms	10 sources — open the full entry
Asenapine Maleatevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Atenolol + Chlorthalidonevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Atomoxetine Hydrochloridevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Azilsartan Medoxomil + Chlorthalidonevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Azithromycin Dihydratebase Ophthalmicvia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Baloxavir Marboxilvia Zinc sulfate	Moderate	Absorption	Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed…	3 sources — open the full entry
Beclometasone + Formoterol + Glycopyrroniumvia Tetryzoline (ophthalmic)	Moderate	Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…	11 sources — open the full entry
Beclomethasone Dipropionate + Formoterol Fumaratevia Tetryzoline (ophthalmic)	Moderate	Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…	11 sources — open the full entry
Betamethasonevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone + Calcipotriolvia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone + Clotrimazolevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone + Clotrimazole + Gentamicinvia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone + Neomycin Sulphate (Ophthalmic)via Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone + Phenylephrine + Lignocainevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone Dipropionatevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone Dipropionate + Salicylic Acidvia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone Sodium Phosphatevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Betamethasone Valeratevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Bicalutamidevia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Bisoprolol Fumarate + Hydrochlorothiazidevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Budesonide + Formoterol Fumaratevia Tetryzoline (ophthalmic), Zinc sulfate	Moderate	Antagonism · Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…2 documented mechanisms	15 sources — open the full entry
Budesonide + Glycopyrronium Bromide + Formoterol Fumaratevia Tetryzoline (ophthalmic), Zinc sulfate	Moderate	Antagonism · Synergy	Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…2 documented mechanisms	15 sources — open the full entry
Bumetanidevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Bupropion Hydrochloridevia Tetryzoline (ophthalmic)	Moderate	Synergy	Translated with DeepL	4 sources — open the full entry
Cabozantinibvia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry
Calcium Dobesilate + Lidocaine + Dexamethasonevia Zinc sulfate, Glycerin	Moderate	Antagonism	The overuse or abuse of laxatives can cause significant loss of electrolytes and potentiate the risk of hypokalemia associated with corticosteroid therapy…2 documented mechanisms	11 sources — open the full entry
Candesartan Cilexetil + Hydrochlorothiazidevia Glycerin	Moderate	Synergy	The chronic use or abuse of laxatives may potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes…	5 sources — open the full entry
Captoprilvia Glycerin	Moderate	Synergy	Although they are frequently combined in clinical practice, diuretics and angiotensin converting enzyme (ACE) inhibitors may have additive effects…	26 sources — open the full entry
Carbamazepinevia Glycerin	Moderate	Synergy	Carbamazepine may cause clinically significant hyponatremia. Data show that the risk of hyponatremia may be additive when carbamazepine and hydrochlorothiazide…	5 sources — open the full entry
Ceftibuten Dihydratevia Zinc sulfate	Moderate	Absorption	Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or…	3 sources — open the full entry
Cephalexinvia Zinc sulfate	Moderate	Absorption	Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or…	3 sources — open the full entry
Cephradinevia Zinc sulfate	Moderate	Absorption	Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or…	3 sources — open the full entry
Ceritinibvia Glycerin	Moderate	Synergy	Bowel cleansing as well as overuse of certain laxatives may cause electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia in…	6 sources — open the full entry

Conditions

Conditions in which Glycerin + Hypromellose + Polyethylene glycol + Tetrahydrozoline + Zinc Sulfate needs care, as documented in this source.

Inflammatory Bowel Diseases
Major
The use of laxatives is contraindicated in patients with inflammatory bowel disease. Patients with inflammatory bowel disease may experience colonic perforation with use of stimulant laxatives.
6 sources
1. "Product Information. Dulcolax (bisacodyl)." Ciba Self-Medication Inc (2001):
2. "Product Information. Fleet Bisacodyl (bisacodyl)." Fleet
3. "Product Information. Kondremul Plain (mineral oil)." Bristol-Myers Squibb
4. "Product Information. Neoloid (castor oil)." Paddock Laboratories Inc (2001):
5. "Product Information. SenoSol-X (senna)." Apothecon Inc (2022):
6. "Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates)." Braintree Laboratories (2010):
Intestinal Obstruction
Major
The use of laxatives is contraindicated in patients with intestinal obstruction disorders. Patients with intestinal obstruction disorders may need their underlying condition treated to correct the constipation. Some laxatives require reduction in the colon to their active form to be effective which may be a problem in patients with intestinal obstruction.
8 sources
1. "Product Information. Dulcolax (bisacodyl)." Ciba Self-Medication Inc (2001):
2. "Product Information. Fleet Bisacodyl (bisacodyl)." Fleet
3. "Product Information. Kondremul Plain (mineral oil)." Bristol-Myers Squibb
4. "Product Information. Fleet Mineral Oil Enema (mineral oil)." Fleet (2001):
5. "Product Information. Citrucel (methylcellulose)." SmithKline Beecham (2001):
6. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratories Inc (2001):
7. "Product Information. SenoSol-X (senna)." Apothecon Inc (2022):
8. "Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates)." Braintree Laboratories (2010):
Kidney Diseases
Moderate
The trace metals, chromium and zinc, are excreted primarily in the urine. Selenium is partially excreted in the urine. Supplemental doses of these agents may need to be adjusted, reduced, or omitted in patients with renal dysfunction.
3 sources
1. "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA (2001):
2. "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc (2022):
3. "Product Information. Sele-Pak (selenium)." Fujisawa
Malabsorption Syndromes
Moderate
The trace metals manganese, chromium, copper, selenium, and zinc are absorbed in the GI tract from dietary sources and following administration of oral supplements. GI absorption may be decreased in patients with malabsorption syndromes. Therefore, larger dosages may be required when these supplements are given orally. Parenteral administration may be appropriate.
6 sources
1. "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA (2001):
2. "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc (2022):
3. "Product Information. Sele-Pak (selenium)." Fujisawa
4. "Product Information. Copper Sulfate (copper sulfate)." Humco Holding Group (2001):
5. "Product Information. Manganese Chloride (manganese chloride)." Abbott Pharmaceutical (2001):
6. "Product Information. Manganese Sulfate (manganese sulfate)." American Regent Laboratories Inc (2001):

Medicines

Conditions

Inflammatory Bowel Diseases

Intestinal Obstruction

Kidney Diseases

Malabsorption Syndromes